Dr. William Todd Dauer M.D.
Neurologist | Neurology
710 W 168th St New York NY, 10032About
Dr. William Dauer is a distinguished Neurologist in New York, NY. Dr. Dauer specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Dauer employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Dauer is committed to staying abreast of the latest developments in neurological research and therapies.
Education and Training
Washington Univ Sch Of Med- St Louis Mo 1990
Board Certification
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The ons and offs of inducible transgenic technology: a review.
- Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.
- Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.
- alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.
- Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.
- The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein.
- Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope.
- Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance.
- A critical evaluation of the Braak staging scheme for Parkinson's disease.
- The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration.
- Transcriptional and proteomic profiling in a cellular model of DYT1 dystonia.
- Primary dystonia: molecules and mechanisms.
- The WD40 domain is required for LRRK2 neurotoxicity.
- A molecular mechanism underlying the neural-specific defect in torsinA mutant mice.
- Lethal toxicity caused by expression of shRNA in the mouse striatum: implications
Professional Memberships
- Member American Academy of Neurology
- Member American Neurological Association
- Member Society for Neuroscience
- Member Movement Disorders Society
Fellowships
- Neurosciences, Massachusetts General Hospital 1992
- Movement Disorders, New York Presbyterian Medical Center 1997
Dr. William Todd Dauer M.D.'s Practice location
Dr. William Todd Dauer M.D.'s reviews
Write ReviewPatient Experience with Dr. Dauer
Recommended Articles
- What to Do When a Person Is Having an Episode of Seizure: Basic First Aid
Epilepsy is a range of conditions that affect the brain’s electrical activity. Although there are many types of epilepsy, most of them are characterized by seizures that are unpredictable. People with epilepsy will experience different symptoms depending on the type of seizure they have....
- Multiple Sclerosis Treatments Are Becoming More Effective, but Are Underfunded
Multiple sclerosis is considered a relatively rare disease, but a recent MS guideline published by the National Institute for Health and Care Excellence stated that with more than 400,000 cases in the US alone, MS has become the leading cause of physical disability in working age adults.Although...
- Dystonia: What Does This Symptom Look Like in Parkinson's Patients?
We all know that tremors and slow movement are part of Parkinson’s, but what about contracting muscles, intense pain, and even limited mobility? For many, this is their reality and it’s caused by a disorder that is called dystonia. ...
- The Financial Burden of Alzheimer's for Caregivers
As medical professionals have continued to discover the various diseases that exist today, some more than others stand out as bringing serious repercussions to not only the patient, but those looking after them. One specific disease that brings with it serious repercussions is dementia. This disease...
- New Research Disproves Link Between Alzheimer's and Heartburn Drugs
Previous studies have found an association between common heartburn medications and an increased risk of AD. However, more recent studies have reached other conclusions.A group of researchers from Germany found that proton pump inhibitors (PPIs), including commonly used medications such as Nexium,...
- Alzheimer's Cases Expected to Quadruple by 2050
Alzheimer’s disease is among the conditions with the most surprising projections for the next 50 years as the numbers of diagnoses are expected to quadruple. But, why? Alzheimer’s disease is a condition that modifies a patient's lifestyle entirely. Although a cure for this neurodegenerative...
Nearby Providers
- Dr. Ian A. Stein MD170 Great Neck Road Great Neck New York 11021
- Dr. Tibor Becske M.D.560 1st Ave New York NY 10016
- Dr. Paul Herberton Gordon M.D.710 W 168th St New York NY 10032
- Dr. Dale J. Lange M.D.800A 5th Ave Ste 203 New York NY 10065
- Dr. Anup Panduranga M.D.300 Community Dr Manhasset NY 11030
- Dr. Nilay R. Shah MD725 River Rd Edgewater NJ 07020